CLINICAL_TRIALS
trial_result
· 2020-01-23
Clinical Trial Update: Comparative FK506 Drug Levels of Once Daily Advagraf in First Nations and Caucasian Patients With Liver Transplants [Phase 4]
Summary
Phase 4 trial comparing FK506 (advagraf) drug levels between First Nations and Caucasian liver transplant patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Manitoba | Conditions: Liver Failure | Phase 4 | Status: COMPLETED